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The subcellular dtstribution of annexin V, a calcium-dependent phosphohpid- and membrane-binding protein, in a human-derived cell line, GL15, 
was investigated by immunocytochemistry at light and electron microscope levels. Annexm V was found diffusely in the cytoplasm and associated 
with plasma membranes, membranes dehmiting cytoplasmic vacuoles, membranes of the endoplasmic reticulum. and filamentous structures the 
identity of which remains to be estabhshed. By immunocytochemistry at the light microscope level and immunochemistry, the expression of annexin 
V in these cells was found to depend on cellular growth state, being maximal soon after plating and progressively declining thereafter. However, 
re-expression of annexin V was observed whenever cell proliferation slowed down or arrested. These findings suggest that annexin V in glioma 
cells is mostly expressed in connection with cell differentiation. Also, the present ultrastructural data suggest that plasma membranes, membranes 
of the endoplasmic rettculum and the cytoskeleton are prominent sites of action of annexin V in vivo. thus lending support to the possibility that 
this protein might have a role m the regulation of cytoskeleton elements and/or of the structural organizatton of membranes. 
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1. INTRODUCTION 
In recent years, the search for intracellular proteins 
potentially involved in the regulation of stimulus-re- 
sponse coupling led to the identification of a novel fam- 
ily of Ca”-binding proteins, the annexins, structurally 
unrelated to Ca”-binding proteins of the EF-hand type 
(for reviews see [l-5]). The annexin family comprises at 
least ten members in vertebrates, each of which has been 
given different names by investigators in the laborato- 
ries where individual proteins have been isolated and 
characterized [6]. The annexins, which have been sug- 
gested to play a role in the regulation of exocytosis, cell 
growth, the structural organization of membranes, 
blood coagulation, and the inflammatory response, 
share the ability to bind to acidic phospholipids and 
natural membranes in a Ca2’-dependent way. 
Two proteins, CaBP33 and CaBP37, purified from 
bovine brain by Ca”-dependent affinity chromatogra- 
phy on phenyl-Sepharose [7], were shown to be annex- 
ins [8]. Amino acid sequence analysis revealed that 
CaBP33 is the brain form of annexin V, whereas 
CaBP37 is an isoform of annexin V [9], which has been 
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detected only in bovine tissues thus far [S,lO,ll]. Al- 
though annexin V has been suggested to have Cal+- 
channel activities [12,13], and demonstrated to be a po- 
tent anticoagulant [l&16] and to inhibit protein kinase 
C [17], its biological role(s) is (are) not known. Annexin 
V has been shown to be widely distributed in animal 
tissues by both immunochemistry and immunocyto- 
chemistry [18-211. Yet, it is not ubiquitous. Following 
the observation that in the central and peripheral nerv- 
ous system annexin V is restricted to glial cells [2&22], 
we analyzed the expression of this protein in a human- 
derived glioma cell line, GL15 [23]. Our data indicate 
that: (i) GL15 glioma cells express annexin V (CaBP33). 
but not its isoform, CaBP37; (ii) annexin V in these cells 
is found diffusely in the cytoplasm as well as associated 
with plasma membranes, membranes of the endoplas- 
mic reticulum, and filamentous (cytoskeletal) struc- 
tures; and (iii) the expression of the protein in these cells 
changes as a function of growth state, being high when- 
ever the mitotic index is low, e.g. during the first post- 
plating day or following serum deprivation. 
2. MATERIALS AND METHODS 
2.1. Protern purification and characterizatzon of the anti-annexin V 
antisewn 
The CaBP33KaBP37 mixture was purified from bovine brain as in 
[7]. Annexm V (CaBP33) was purified from porcine heart as in [lo]. 
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Annexin V was used to nnmumze rabbits as in [8]. The anti-annexm 
V antiserum used m the present study was shown to be specific to 
annexm V when tested with cytosolic fractions or with EGTA- or 
Tnton X-loo-extracts of membranes from rat and porcine organs by 
immunoblottmg [S,lO.ZO] Wtth bovine tissues, this antiserum also 
recognized the annexin V isoform. CaBP37. but no immunological 
cross reactivity was observed between annexm V isoforms and other 
annexms [8.10] 
GLI 5 ghoma cells were plated on 35-mm plastic Petri dishes at a 
density of 2 x IO5 cells/dish and cultured for one day m DMEM sup- 
plemented with 20% heat-inactivated fetal calf serum and 100 IU of 
pemctllin and 0.1 mg of streptomycm/ml. Cells were washed free of the 
culture medium with 20 mM Tris-HCI, pH 7.5. containing 0.9% NaCl 
(TBS) and fixed with 3% glutaraldehyde m TBS for IO min at room 
temperature. Cells were washed free of the fixative with TBS. dehy- 
drated in a series of alcohols and propylene dioxide. and embedded 
in Epon-Araldite. Thin sections were mounted onto nickel grids and 
sequentially incubated for 5 min m 3% bovine serum albumm (BSA) 
m TBS (buffer A) containing 20 mM NaN, (buffer B). and for IO min 
m 20 mM glycine in buffer B. This step was followed by incubatton 
.- 
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with the anti-annexm V antiserum (I:100 in buffer B. 1 h at room 
temperature and then overnight at 4°C. in a humid chamber). Sections 
were washed with buffer B containing 1% Tween-20 (five times, I min 
each). and Incubated for 3 h at room temperature with a goat-anti- 
rabbit IgG antibody labelled with I5 nm gold particles (Biocell Re- 
search Laboratories. Cardiff. UK) (I: 100 in buffer B). Sections were 
washed with buffer B mmus BSA (buffer C) (once for 1 mm), post- 
fixed for 3 min with 1% glutaraldehyde m buffer C. and counterstamed 
with uranyl acetate and lead citrate Sections were viewed m a Philips 
TEM 400 electron microscope. In control experiments, the primary 
anttserum was either omitted. substituted for by the pretmmune 
serum, or absorbed wtth annexm V before use. Identical results were 
obtained, irrespective of the procedure used, i.e. no immune reaction 
was detected. 
In other experiments, CL 15 cells were plated on glass coverslips in 
Costar tissue culture plates at a density of 5 x 10” cells/well (1 6 cm in 
diameter) and cultured as above for one day. Cells were washed free 
of the culture medium and fixed as above. Fixed cells were permeabil- 
ized with 0 1% Triton X-100 m TBS for 10 mm at room temperature. 
and exposed to 3% HzOl m methanol for 15 mm to quench any 
endogenous peroxidase activity. Cells were then incubdted m buffer 
A for 3 h at room temperature followed by incubation with the anti- 
Fig. I Immunocytochemical localization of annexin V m human GL15 glioma cells. Electron microscope analysis by post-embedding immunocy- 
tochemistry. immune reaction product is observed on plasma membranes (arrows in A and D), in association with intermediate filaments m the 
cell body (arrowheads m B, also see D and F) and in cell processes (arrowheads in C and G). on membranes limiting cytoplasmtc vacuoles (arrows 
m B). and on membranes of the endoplasmic reticulum (arrows m E). Annexin V is also found diffusely in the cytoplasm (A.B.D). Control sections 
show no immune reaction product (H). Bars: A-H = 0 I pm. 
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annexin V antiserum (1 :lOO in 1% BSA m TBS) overnight at 4°C. This 
step was followed by sequential incubations of cells with a sheep-anti- 
rabbit IgG antiserum (1:lOO in 1% BSA in TBS) and with a horse- 
radish peroxtdase-anti-peroxidase complex (I: 200 m 1% BSA in 
TBS), each for 1 h at room temperature. Washmgs between antisera 
were done with 0.2% Triton X-100 in TBS. The immune reaction 
product was developed using 0.3 mg of diaminobenzidme (DAB)/ml 
of 50 ml mM Tris-HCI, pH 7.5. containing 0.02% HzOz. in the dark. 
Cells were washed m TBS and mounted m a permanent aqueous 
medium on glass slides for light microscopy. Control experiments were 
done as described above. 
2.3. Immunochenncal analyses 
To quantitate annexin V in GL15 cells, cells were plated on 35-mm 
plastic Petri dishes and cultivated for 1,2.4, 7, 11. or 18 days. On the 
day of expertments, cells were washed free of the medium with TBS 
and extracted with 0.2 ml of a solution of 3% SDS m 50 mM Tris-HC1, 
pH 7.5 for 15 min at room temperature, after which 2-mercaptoetha- 
no1 was added to a final concentration of 5%. Cell extracts were boiled 
for 5 min and subjected to SDS-PAGE (7.5% acrylamide) [24] in 
parallel with known amounts of annexin V which served as a reference. 
The polypeptides so separated were electroblotted onto nitrocellulose 
paper and subjected to rmmunostaining [25] using the anti-annexm V 
antiserum (1:lOOO). The immune reaction product was developed 
using DAB as described above. Immunoreactive bands on nitrocellu- 
lose sheets were subjected to densitometry for quanttfication of an- 
nexm V. Cells grown in parallel dishes were used to measure the total 
protein content [26]. To measure the amount of annexm V/cell. cells 
were plated in 96-multiwell plates at a density of 7 x 10’ cells/well and 
cultivated as above for 1. 2, 4. 7, 11, or 18 days. On the day of 
experiments, cells were processed as described for light mtcroscopy 
(see section 2.2.). except that the immune reaction product was devel- 
oped with a solution of 4 mM o-phenylenediamine m 50 mM citric 
acid, 100 mM Na,HPO,, pH 5.0. containing 0.01% H,Oz (50 ~llwell 
for 10 min in the dark), followed by 50 ,uI of 4 N H,SO, to termmate 
the reaction. The immune reaction product was measured spectro- 
photometrically at 492 nm using a microplate reader photometer. In 
control experiments, the prtmary antiserum was omitted. Cells seeded 
in parallel 96-multrwell plates were used to calculate the number of 
cells/well at the different post-plating days by a tetrazohum-based 
(MTT) calorimetric assay [27]. 
3. RESULTS AND DISCUSSION 
The anti-annexin V antiserum recognized both bo- 
vine isoforms of annexin V, but only one polypeptide 
in extracts from GL15 glioma cells by immunoblotting 
(not shown). This polypeptide comigrated with annexin 
V (CaPB33) in SDS gels, indicating that GL15 cells 
express only the lower M, isoform of annexin V. 
By immunocytochemistry using the immunogold 
(post-embedding) method, annexin V was found dif- 
fusely in the cytoplasm as well as associated with plasma 
membranes, intermediate filaments, and membranes of 
the endoplasmic reticulum (Fig. 1). 
Fig. 2 documents changes occurring in the expression 
of annexin V in Gil 5 cells as a function of cellular 
growth state, as investigated by immunocytochemistry 
at the light microscope level. Cells were cultivated for 
1-18 days in the presence of serum with renewal of the 
medium every other day. The maximum expression of 
the protein/cell was observed between day 1 and day 2 
after plating, as judged by light microscopy (Fig. 2A,B), 
with a progressive decrease in the expression of annexin 
V during the subsequent post-plating days. From the 
eleventh day only a faint immunoreactivity could be 
seen in these cells (Fig. 2E,F). Under the present exper- 
Ftg. 2. Immunocytochemical localization of annexin V in human GL15 glioma cells as a function of cellular growth state. Cells were plated on 
glass coverslips in tissue culture cluster plates and cultivated for 1 (A). 2 (B), 4 (C). 7 (D), 11 (E). or 18 (F) days in the presence of serum, before 
tmmunocytochemtstry. The culture medium was renewed every other day. The maximum expression of the protein/cell IS apparently observed 
between the first (A) and second (B) post-plating day. Then, the intensity of the Immune reaction product progressively dechnes, although some 
residual immunoreactivity is still observable at the eighteenth post-platmg day (F). Bars: A-F = 50 pm. 
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imental conditions, confluency was apparently attained 
around the fourth post-plating day (Fig. 2C). 
A more thorough analysis of the proliferation pattern 
of GL15 cells by cell count and protein determination 
(Fig. 3) revealed that the maximum expression of an- 
nexin V/cell occurred at day 1, and that the annexin V 
content declined to very low levels as cells proliferated, 
such that at day 18 the annexin V content/cell was about 
4% of that at day 1 (Fig. 3A). Also, in the time period 
investigated these cells proliferated in an almost linear 
way when cultivated in the presence of serum (Fig. 3B). 
Immunoblots of SDS-extracts of GL15 cells cultivated 
for 1-18 days showed that at day 1 the annexin V con- 
centration was 8.33 ,&mg of protein, becoming 0.41 
,ug/mg of protein at day 18 (Table I). As the data in Fig. 
3 and Table I suggested that the expression of annexin 
V in GL15 cells negatively correlated with cell prolifer- 
ation, several culture conditions were tested to see 
whether or not the expression of annexin V could be 
correlated with cell differentiation. 
(1) When cells were cultivated in the presence of 
serum without renewing the medium, cell proliferation 
was linear up until day 7, and decreased significant 
thereafter (Fig. 4, n ). Under these conditions, the an- 
nexin V content/cell decreased to nearly the same levels 
as in the reference experiment (serum renewed every 
other day) from day 1 to day 11, and significantly in- 
creased from day 11 to day 18 as compared to the 
reference experiment (Fig. 4, 0). 
(2) When cells were grown in the presence of serum 
Culture trme, days 
Fig. 3. Immunochemtstry of annexin V in human GL15 ghoma cells 
as a function of culture time. (A) The annexm V content/cell was 
measured on cells cultivated in 96-multiwell plates for the time indi- 
cated in the presence of DMEM supplemented with fetal calf serum. 
The medium was renewed every other day. Annexin V immunochem- 
istry was done as described m section 2.3. Results are expressed as A,,> 
vs. the culture time. (B) Cells were plated in 96-multiwell plates (0) or 
in 35-mm plasttc Petri dishes (0) and cultivated as described above. 
Cells plated on 96-multtwell plates were used for cell counting by the 
MTT method (o), whereas cells plated on Petrt dishes were used for 
protein determination CO). Under the present experimental conditions. 
the rmmunocytochemical counterpart of which was illustrated m Fig. 
2, the annexin V content/cell fell down to very low levels by the end 
of the first post-plating week (A). whereas cells proliferated in an 
1 8.33 f 0.64 
2 6.07 & 0.58 
4 2.11 f 0.18 
I 1.13 + 0.08 
11 0.94 + 0 03 
18 0.41 f 0.04 
GL15 glioma cells were plated at a density of 2 x IO5 cells/dish m 
parallel 35-mm plastic Petri dishes and culttvated for l-18 days in 
DMEM supplemented with 20% fetal calf serum. The medium was 
renewed every other day. At intervals as indicated, cells were washed 
free of the medium with TBS and solubtlized wtth etther SDS plus 
2-mercaptoethanol for SDS-PAGE and tmmunostaining with the anti- 
annexin V antiserum after transfer of separated polypeptides onto 
nitrocellulose paper, or 0.1 M NaOH plus 0.19 M NaCO, for protein 
determinatron. Known amounts of annexin V were subjected in paral- 
lel to immunoblotting and served as reference to quantitate annexm 
V in immunoblots of SDS-extracts. Figures represent the mean of 
almost linear way during the time period investigated (B). three determmations & S.E 
4 8 12 16 
Culture ttrne. days 
Culture ttme, days 
Fig. 4. Immunochemtstry of annexin V m human GL15 ghoma cells 
as a function of culture time under different culture conditions. The 
percent amount of annexm V/cell was plotted vs. the culture time. (0) 
Data m Fig. 3A were included for comparison. (m) Cells were cultt- 
vated as m (o), except that the culture medium was not renewed (a) 
Cells were cultivated as m (0). except that at day 2 the medium was 
substituted for by DMEM alone. (v) Cells were cultivated as in (0). 
except that at day 4 the medium was substituted for by DMEM alone. 
(0) Cells were plated m DMEM alone and cultivated for 11 days 
without renewing the medium. Cell counts under the different culture 
condittons are reported in the inset. Note that changing the culture 
medium at day 4 to DMEM alone (v) resulted in a 3-fold increase in 
the annexin V content/cell during the next three days along with an 
arrest m cell prohferatton. Also. when cells mere plated and cultivated 
in DMEM alone (o), the maximum content of annexin V/cell was 
observed at day 2 and its level remained srgnificantly higher than m 
the reference experiment (0) between day 4 and day 7. 
for two days and in DMEM without serum thereafter 
(Fig. 4, n), the decrease in the annexin V content/cell 
was less steep from day 2 to day 4, as compared to the 
reference experiment, increased to some extent from 
day 4 to 7, and decreased thereafter to values signifi- 
Table I 
Content of annexin V in human GL15 ghoma cells as a function of 
cellular growth state 
Post-plating day Annexm V (,&mg of protein) 
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Fig. 5. Immunocytochemistry of annexin V in human GL15 glioma cells cultivated in DMEM alone for 11 days. Conditions were as described 
in Fig. 4, except hat cells were cultivated in the absence of serum for 1 (A), 2 (B), 4 (C), 7 (D), or 1 I (E) days without renewing the medium. Note 
that under these conditions cells acquired a stellate shape and expressed significant levels of annexm V even at day 11. Bars: A-E = 15 pm. 
cantly higher than those registered in the reference ex- 
periment. This pattern was congruent with cell counts 
and protein determination, in that the increase in an- 
nexin V content/cell observed between day 4 and day 7 
coincided with an arrest of cell proliferation. 
(3) When cells were cultivated for four days in the 
presence of serum with renewal of the medium every 
other day, followed by serum deprivation, the prolifera- 
tion rate sensibly decreased during the next three days 
(Fig. 4, v). During this time period, the annexin V con- 
tent/cell increased by more than thrice, as compared to 
the reference experiment. 
(4) Since the results of experiments (2) and (3) sug- 
gested that the annexin V content/cell negatively corre- 
lated with proliferation, one additional experiment was 
done, in which cells were cultivated for 11 days without 
renewing the medium in the absence of serum since the 
beginning. In this case, in addition to cell count, protein 
determination, and measurement of annexin V im- 
munoreactivity in cells seeded in 96-multiwell plates, 
immunocytochemistry at the light microscope level was 
carried out. Under these conditions (Fig. 4, o), cells 
stopped proliferating from day 1 to day 2, restarted 
proliferating from day 2 to day 7, albeit at a signifi- 
cantly slower rate than in the reference experiment, and 
almost arrested between day 7 and day 11. The maxi- 
mum expression of annexin V content/cell was regis- 
tered at day 2. At day 4, cells contained twice as much 
annexin V as the corresponding cells of the reference 
experiment, and, in spite of some proliferation between 
day 7 and day 11, the annexin V content remained 
constant in this time period. All these data were consis- 
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tent with the possibility that the expression of annexin 
V in GL15 glioma cells is related to differentiation 
rather than to proliferation. Immunocytochemistry at 
the light microscope level (Fig. 5) showed that annexin 
V was expressed in cells cultivated for as long as eleven 
days in the absence of serum without renewal of 
the medium. and that serum deprivation induced these 
cells to acquire a stellate shape (compare Fig. 5 with 
Fig. 2). 
No annexin V immunoreactivity was found in neu- 
rons [20-221 or in rat chromaffin cells [20]. On the other 
hand, by immunochemical dosage, annexin V was 
found to be expressed in extremely low amounts in 
NGF-untreated rat pheochromocytoma (PC12) cells 
and to be expressed in high amounts in NGF-treated 
PC12 cells as long as these cells were exposed to NGF 
[28]. Also, the amount of annexin V in cultured fibrob- 
lasts, as measured immunochemically, was maximal at 
confluency and remained constant during the post-con- 
fluency time, at which time no further cell proliferation 
occurred [28]. These data were interpreted as indicating 
that annexin V accumulated in the above cell types dur- 
ing cell differentiation, rather than during cell prolifera- 
tion. In the case of GL15 glioma cells, by both immuno- 
chemistry and immunocytochemistry the annexin V 
level was found to be high during the first two post- 
plating days when cells were cultivated in the presence 
of serum, and to progressively decline to almost zero 
while cells were still actively proliferating. However, 
whenever cell proliferation decreased or arrested, reac- 
cumulation of annexin V was observed. in agreement 
with the conclusion that annexin V is mostly expressed 
during cell differentiation. Qualitatively identical results 
were obtained with antisera specific to S-100 protein, 
the glial fibrillary acidic protein. and annexin VI (un- 
published data), suggesting that these latter proteins, 
too, are expressed and exert their activities in differenti- 
ated cells. 
In conclusion, we have offered evidence for associa- 
tion of annexin V with membranes and cytoskeletal 
structures in vivo. This subcellular distribution was seen 
whenever annexin V was allowed to accumulate in gli- 
oma cells, i.e. soon after plating and/or after serum 
deprivation. This latter treatment resulted in remarka- 
ble changes in cell morphology, suggestive of differenti- 
ation. The above sites, i.e. membranes and intermediate 
filaments, thus appear to be physiological targets of 
annexin V, although the functional link between these 
two subcellular localizations of the protein is still miss- 
ing. Recently, evidence for Ca”+-dependent self-associa- 
tion of several annexins in vitro has been presented [4]. 
An attractive possibility might therefore be that annexin 
V, the dimerization of which has been described 
[16,29,30], serves the function of connecting cytoskeletal 
structures to the lipid bilayer of cell membranes. Ac- 
cordingly. annexin V accumulates in glioma cells during 
differentiation. 
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